OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Re‐examining the widespread policy of stopping sodium‐glucose cotransporter‐2 inhibitors during acute illness: A perspective based on the updated evidence
Kamlesh Khunti, Vanita R. Aroda, Deepak L. Bhatt, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 11, pp. 2071-2080
Open Access | Times Cited: 31
Kamlesh Khunti, Vanita R. Aroda, Deepak L. Bhatt, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 11, pp. 2071-2080
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Applications of SGLT2 inhibitors beyond glycaemic control
Daniel V. O’Hara, Carolyn S.P. Lam, John J.V. McMurray, et al.
Nature Reviews Nephrology (2024) Vol. 20, Iss. 8, pp. 513-529
Closed Access | Times Cited: 26
Daniel V. O’Hara, Carolyn S.P. Lam, John J.V. McMurray, et al.
Nature Reviews Nephrology (2024) Vol. 20, Iss. 8, pp. 513-529
Closed Access | Times Cited: 26
Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement
Kariem El‐Boghdadly, Jugdeep Dhesi, Philippa Fabb, et al.
Anaesthesia (2025)
Open Access | Times Cited: 8
Kariem El‐Boghdadly, Jugdeep Dhesi, Philippa Fabb, et al.
Anaesthesia (2025)
Open Access | Times Cited: 8
Discontinuation and reinitiation of SGLT-2 inhibitors and GLP-1R agonists in patients with type 2 diabetes: a nationwide study from 2013 to 2021
Mariam Elmegaard Malik, Alexander Christian Falkentoft, J. Steen Jensen, et al.
The Lancet Regional Health - Europe (2023) Vol. 29, pp. 100617-100617
Open Access | Times Cited: 33
Mariam Elmegaard Malik, Alexander Christian Falkentoft, J. Steen Jensen, et al.
The Lancet Regional Health - Europe (2023) Vol. 29, pp. 100617-100617
Open Access | Times Cited: 33
Early Identification and Management of Chronic Kidney Disease: A Narrative Review of the Crucial Role of Primary Care Practitioners
Pamela Kushner, Kamlesh Khunti, Ana Cebrián, et al.
Advances in Therapy (2024) Vol. 41, Iss. 10, pp. 3757-3770
Open Access | Times Cited: 7
Pamela Kushner, Kamlesh Khunti, Ana Cebrián, et al.
Advances in Therapy (2024) Vol. 41, Iss. 10, pp. 3757-3770
Open Access | Times Cited: 7
Evaluation of glucose-lowering medications in older people: a comprehensive systematic review and network meta-analysis of randomized controlled trials
Ssu-Yu Pan, En-Lin Su, Chi‐Jung Huang, et al.
Age and Ageing (2024) Vol. 53, Iss. 8
Closed Access | Times Cited: 6
Ssu-Yu Pan, En-Lin Su, Chi‐Jung Huang, et al.
Age and Ageing (2024) Vol. 53, Iss. 8
Closed Access | Times Cited: 6
Association of Glucose-Lowering Drugs With Outcomes in Patients With Diabetes Before Hospitalization for COVID-19
Zheng Zhu, Qingya Zeng, Qinyu Liu, et al.
JAMA Network Open (2022) Vol. 5, Iss. 12, pp. e2244652-e2244652
Open Access | Times Cited: 24
Zheng Zhu, Qingya Zeng, Qinyu Liu, et al.
JAMA Network Open (2022) Vol. 5, Iss. 12, pp. e2244652-e2244652
Open Access | Times Cited: 24
Timing of SGLT2i initiation after acute myocardial infarction
Dirk von Lewinski, Ewald Kolesnik, Faisal Aziz, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Dirk von Lewinski, Ewald Kolesnik, Faisal Aziz, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials
Claire L. Vale, Peter J. Godolphin, David J. Fisher, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 10, pp. 735-747
Open Access | Times Cited: 5
Claire L. Vale, Peter J. Godolphin, David J. Fisher, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 10, pp. 735-747
Open Access | Times Cited: 5
Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms
Ronald Goldenberg, Jeremy Gilbert, Robyn L. Houlden, et al.
Current Medical Research and Opinion (2025), pp. 1-17
Closed Access
Ronald Goldenberg, Jeremy Gilbert, Robyn L. Houlden, et al.
Current Medical Research and Opinion (2025), pp. 1-17
Closed Access
Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential
Konstantinos Arvanitakis, Theocharis Koufakis, Georgios Kalopitas, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 18, Iss. 1, pp. 102935-102935
Closed Access | Times Cited: 9
Konstantinos Arvanitakis, Theocharis Koufakis, Georgios Kalopitas, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 18, Iss. 1, pp. 102935-102935
Closed Access | Times Cited: 9
Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs – The CAPISCO International Expert Panel
Djordje S. Popovic, Νικόλαος Παπάνας, Theocharis Koufakis, et al.
Experimental and Clinical Endocrinology & Diabetes (2023) Vol. 131, Iss. 05, pp. 260-267
Closed Access | Times Cited: 8
Djordje S. Popovic, Νικόλαος Παπάνας, Theocharis Koufakis, et al.
Experimental and Clinical Endocrinology & Diabetes (2023) Vol. 131, Iss. 05, pp. 260-267
Closed Access | Times Cited: 8
Underuse of glucose-lowering medications associated with cardiorenal protection in type 2 diabetes: from delayed initiation to untimely discontinuation
André Scheen
The Lancet Regional Health - Europe (2023) Vol. 29, pp. 100627-100627
Open Access | Times Cited: 8
André Scheen
The Lancet Regional Health - Europe (2023) Vol. 29, pp. 100627-100627
Open Access | Times Cited: 8
Empagliflozin-associated postoperative mixed metabolic acidosis. Case report and review of pathogenesis
Michal Šitina, Marek Lukeš, Vladimír Šrámek
BMC Endocrine Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Michal Šitina, Marek Lukeš, Vladimír Šrámek
BMC Endocrine Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Potential use of sodium glucose co-transporter 2 inhibitors during acute illness: a systematic review based on COVID-19
Carmen Tisch, Eleni Xourgia, Aristomenis K. Exadaktylos, et al.
Endocrine (2024) Vol. 85, Iss. 2, pp. 660-675
Open Access | Times Cited: 2
Carmen Tisch, Eleni Xourgia, Aristomenis K. Exadaktylos, et al.
Endocrine (2024) Vol. 85, Iss. 2, pp. 660-675
Open Access | Times Cited: 2
Association of anti-diabetic drugs and covid-19 outcomes in patients with diabetes mellitus type 2 and chronic kidney disease: Nationwide registry analysis
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0301056-e0301056
Open Access | Times Cited: 2
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0301056-e0301056
Open Access | Times Cited: 2
A Systematic Review and Meta-analysis on the Safety and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitor Use in Hospitalized Patients
Frank Gao, Aleena S. Ali, Rinaldo Bellomo, et al.
Diabetes Care (2024) Vol. 47, Iss. 12, pp. 2275-2290
Closed Access | Times Cited: 2
Frank Gao, Aleena S. Ali, Rinaldo Bellomo, et al.
Diabetes Care (2024) Vol. 47, Iss. 12, pp. 2275-2290
Closed Access | Times Cited: 2
Non-Insulin Novel Antidiabetic Drugs Mechanisms in the Pathogenesis of COVID-19
Teodor Salmen, Valeria-Anca Pietroșel, Bianca-Margareta Mihai, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2624-2624
Open Access | Times Cited: 11
Teodor Salmen, Valeria-Anca Pietroșel, Bianca-Margareta Mihai, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2624-2624
Open Access | Times Cited: 11
Gaps in our knowledge of managing inpatient dysglycaemia and diabetes in non‐critically ill adults: A call for further research
Ketan Dhatariya, Guillermo E. Umpierrez
Diabetic Medicine (2022) Vol. 40, Iss. 3
Open Access | Times Cited: 10
Ketan Dhatariya, Guillermo E. Umpierrez
Diabetic Medicine (2022) Vol. 40, Iss. 3
Open Access | Times Cited: 10
Initiation and Continuation of Sodium–Glucose Cotransporter 2 Inhibitors in Hospital Inpatients: Ready for Prime Time?
Ketan Dhatariya
Diabetes Care (2022) Vol. 45, Iss. 12, pp. 2806-2807
Open Access | Times Cited: 8
Ketan Dhatariya
Diabetes Care (2022) Vol. 45, Iss. 12, pp. 2806-2807
Open Access | Times Cited: 8
The effects of sodium-glucose cotransporter 2 inhibitors beyond the cardio-renal-metabolic spectrum: will gliflozins have a different fate than statins?
Theocharis Koufakis, Vasilis Tsimihodimos, Symeon Metallidis, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 16, pp. 1753-1756
Open Access | Times Cited: 4
Theocharis Koufakis, Vasilis Tsimihodimos, Symeon Metallidis, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 16, pp. 1753-1756
Open Access | Times Cited: 4
The Reasons for the Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects—A Family Doctor Perspective
Tomislav Kurevija, Dunja Šojat, Zvonimir Bosnić, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1617-1617
Open Access | Times Cited: 1
Tomislav Kurevija, Dunja Šojat, Zvonimir Bosnić, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1617-1617
Open Access | Times Cited: 1
Evaluation of the Lifetime Benefits of Metformin and SGLT2 Inhibitors in Type 2 Diabetes Mellitus Patients with Cardiovascular Disease: A Systematic Review and Two-Stage Meta-Analysis
Hon Jen Wong, Norman Lin, Yao Neng Teo, et al.
American Journal of Cardiovascular Drugs (2024) Vol. 24, Iss. 3, pp. 371-383
Closed Access | Times Cited: 1
Hon Jen Wong, Norman Lin, Yao Neng Teo, et al.
American Journal of Cardiovascular Drugs (2024) Vol. 24, Iss. 3, pp. 371-383
Closed Access | Times Cited: 1
Indirect effects of the COVID-19 pandemic on diagnosing, monitoring, and prescribing in people with diabetes and strategies for diabetes service recovery internationally
Martin K. Rutter, Matthew Carr, Alison K. Wright, et al.
Diabetes Research and Clinical Practice (2024) Vol. 212, pp. 111693-111693
Closed Access | Times Cited: 1
Martin K. Rutter, Matthew Carr, Alison K. Wright, et al.
Diabetes Research and Clinical Practice (2024) Vol. 212, pp. 111693-111693
Closed Access | Times Cited: 1
Metabolic acidosis in patients with diabetes 2 undergoing cardiac surgery
Hege Kristin Brekke, Gunhild Holmaas, Marianne C. Astor, et al.
European Journal of Anaesthesiology (2024)
Closed Access | Times Cited: 1
Hege Kristin Brekke, Gunhild Holmaas, Marianne C. Astor, et al.
European Journal of Anaesthesiology (2024)
Closed Access | Times Cited: 1
Successful treatment of nivolumab and ipilimumab triggered type 1 diabetes by using sodium-glucose transporter 2 inhibitor: a case report and systematic review
Makoto Fujiwara, Masaru Shimizu, Tatsuya Okano, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 3
Makoto Fujiwara, Masaru Shimizu, Tatsuya Okano, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 3
